My only guess is that it was a poster presentation and wasn't anything new. Thus nothing to report. What we all want to know and what we'll not hear about is if it garnered any BP interest. We still wait to see if the company will show us that Lympro is the real deal by showing us any type of revenue or "deal" with a major BP. The end game here is to sell the Dx division which I believe the company is feverishly trying to do. The company needs to show money in the bank if they ever want to up list. Just my 2 cents. This is the type of stuff you will never hear from the cult who went off to their "private" board. It's a move out of the page book of Scientology if you ask me. But that is what cultists do.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.